/Investor DB

aMoon — Full Portfolio

64 tracked investments · listed companies and verified rows first

Adicet Bioadicetbio.comNASDAQ: ACETJul 2019

Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer.

BiotechHealthtechMenlo Park, US

Aya Jakobovits(Executive Officer, Director)Nathan Hubbard(Executive Officer)inChen Schor(President, Chief Executive Officer and Director)in

BoardJonathan Silverstein(Director)inCarl Gordon(Director)inFlorent Gros(Director)

Board seatYair Schindel· per SEC Form D

Co-investorsForesite CapitalOrbiMedPontifax Venture CapitalQuan CapitalNovartis Venture FundPureTech Health

Omada Healthomadahealth.comin𝕏NASDAQ: OMDAFeb 2022 · $190M

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Founder)inSean Duffy(Founder)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)inAndrew DiMichele(Founder)

Co-investorsAndreessen HorowitzBlackbird VenturesCanvas VenturesCivilization Ventures Management, LlcDesigner FundEnsemble Labs+19 more

Seerseer.bioinNASDAQ: SEERDec 2019

Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.

BiotechDeep TechHardwareHealthtechBoston, US

Omid Farokhzad(Founder)inPhilip Ma(Executive Officer)Shadi Aryanpour(Executive Officer)David Singer(Director)Omid Cameron Farokhzad(Founder)in

BoardTerrance McGuire(Director)

Co-investorsSoftBank Vision FundSolasta VenturesWingMaverick VenturesPolaris PartnersT. Rowe Price

Sera Prognosticsseraprognostics.comin𝕏NASDAQ: SERAApr 2021 · $100M

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.

BiotechDigital HealthFemTechHealthtechSalt Lake City, US

Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in

BoardMansoor Mirza(Director)

Co-investorsExcelestar VenturesIntermountain HealthOUP (Osage University Partners)UpStart VenturesVivo CapitalCatalyst Health Ventures+1 more

Smith+Nephewsmith-nephew.comin𝕏NYSE: SNN

Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.

HealthtechMedical DevicesSports TechLondon, GB

Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin

Co-investorsAccelmed PartnersAccess Venture PartnersAlphaDrivePeregrine VenturesTargeted Technology Funds

Adcytherixadcytherix.com✓ verified

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.

BiotechHealthtechMedical Devices

Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in

Co-investorsRA CapitalBpifranceAndera PartnersAngelini VenturesKurma PartnersPontifax Venture Capital+1 more

Breeootbreeoot.com✓ verified

Breeoot is a concierge preventive medicine practice where a single primary physician manages a patient's complete health picture across multiple specialties, coordinated through a technology platform designed for continuous care rather than episodic visits.

Digital HealthHealthtechLongevityWellness & Fitness

David Reichman(Co-founder)

Co-investorsIneffable Ventures

Character Biocharacterbio.cominMar 2025✓ verified

Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.

AI & Machine LearningBiotechDigital HealthJersey City, US

Cheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDaniel Elgort(Chief Data and Analytics Officer)inLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in

Co-investorsLuma GroupSanofi VenturesInnovation EndeavorsCantos VenturesCatalio Capital Management, LPDuke Capital Partners+5 more

Iantrekiantrekmed.cominSeries C · Aug 2025 · $42M✓ verified

Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)

BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in

Co-investorsVisionary VenturesCanaan PartnersCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners

Mdclonemdclone.comin𝕏Series B · Aug 2019 · $26M✓ verified

MDClone provides a healthcare data platform that uses synthetic data to support clinical research and care-improvement initiatives, used by health systems such as Intermountain for programs targeting chronic conditions like kidney disease, diabetes, and cardiovascular disease.

AI & Machine LearningData & InfrastructureDigital HealthHealthtech

Ziv Ofek(Co-Founder and President)inBruno Lempernesse(Chief Executive Officer)inAaron Galaznik(Chief Medical Officer)inAlmog Ohayon(Chief Product and Technology Officer)in

Co-investorsLightspeed Venture PartnersOrbiMedWarburg PincusDeclaration PartnersViola Ventures

Scipher Medicinesciphermedicine.comin𝕏Series C · Mar 2021 · $82M✓ verified

Scipher Medicine is a precision immunology company that combines molecular data from autoimmune patients, protein interaction mapping, and AI to match patients with the most effective therapy for immunological diseases.

AI & Machine LearningBiotechDigital Health

Joseph Loscalzo(Founder)Albert-László Barabási(Founder)

Co-investorsKhosla VenturesAlumni VenturesB3 HoldingCobalt VenturesEcho Health VenturesHitachi Ventures+2 more

Better Life Partnersbetterlifepartners.comin𝕏Series B · Aug 2023 · $27M

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.

Digital HealthHealthtechMental HealthHanover, US

Adam Groff(Executive Officer, Director)inJuliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)

BoardJon Lim(Director)in

Board seatYair Schindel· per SEC Form D

Co-investorsAlumni VenturesF-Prime Capital.406 VenturesMaverick Ventures

Satellite Biosatellite.bioSeries A · Mar 2022 · $82M

Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function.

BiotechHealthtechCambridge, US

Christopher Chen(Director, Promoter)inThomas Lowery(Executive Officer)

BoardEllie McGuire(Director)Ling Wong(Director)Sujata Bhatia(Director)William Young(Director)

Board seatYair Schindel· per SEC Form D

Co-investorsAlumni VenturesCatalio Capital Management, LPLightspeed Venture PartnersHighbury HoldingsPolaris PartnersS32

Viractaviracta.comNov 2020SEC filingmedium confidence

Viracta Therapeutics was a precision oncology company.

BiotechHealthtechCardiff, US

James Woody(Director)David Slack(Executive Officer)

BoardIvor Royston(Executive Officer, Director)Patrick Soon-Shiong(Director)Richard Ghalie(Director)

Board seatGur Roshwalb· per SEC Form D · $40M raise · filed Dec 2020

Co-investorsAisling CapitalLatterell Venture PartnersVirtus Inspire Ventures

Air Drair-dr.comin𝕏

Air Doctor is a platform that enables travelers to book appointments with licensed medical professionals in multiple countries via in-person or online visits.

B2B MarketplacesDigital HealthMarketplacesTravel & Hospitality

Jenny Cohen Derfler(CEO and Co-Founder)inYam Derfler(Co-Founder)inEfrat Sagi OfirYegor Kurbachev

Co-investorsMunich Re Ventures

Akoya Biosciencesakoyabio.comin𝕏acquired by Quanterix

Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease.

BiotechDigital HealthMedical DevicesBillerica, US

Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)

BoardRob Hart(Executive Officer)inRobert Shepler(Director)inThomas Raffin(Director)in

Co-investorsStartXTelegraph Hill Partners

AltruBioaltrubio.comSeries A · Apr 2021 · $63M

AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease.

BiotechHealthtech

Co-investorsDelos CapitalRA CapitalBiotechnology Value FundSoleus Capital

Ayalapharmaayalapharma.com

Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.

Biotech

Co-investorsIsrael Biotech Fund

Biolojic Designbiolojic.comin𝕏

Biolojic uses artificial intelligence and machine learning to design programmable antibodies that can dynamically sense and respond to specific patient micro-environments.

AI & Machine LearningBiotechDeep Tech

Yanay Ofran(Founder & CEO)in

Co-investorsOurCrowdWestern Technology Investment

Connie Healthconniehealth.cominJun 2026 · $40M

Connie Health helps older Americans choose and navigate Medicare plans by combining technology with local licensed agents, providing unbiased plan recommendations and an ongoing local care team at no cost to the user.

Digital HealthHealthtechInsurTech

Oded Eran(Co-founder & Chief Executive Officer)inDavid Luna(Co-founder & President)inMichael Scopa(Co-founder & Chief Operations Officer)in

Co-investorsAbstract VenturesJ-VenturesNat TurnerPitangoArkitekt Venturesat.inc/+4 more

Curesponsecuresponse.cominJun 2020 · $6M

Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts.

AI & Machine LearningBiotechDigital HealthHealthtech

Guy Neev(Co-Founder & CEO)inDr. Ravid Straussman(Scientific Founder)Dr. Seth Salpeter(Co-Founder & CTO)Eran Dor(CFO)

Co-investorsNCL Technology Ventures Ltd.

Eleoseleos.co.ukin𝕏

Eleos offers life insurance and income protection to consumers in the UK, with an app-based process that explains cover in plain English, provides instant answers, and connects users to licensed experts by WhatsApp, email, or phone.

FintechInsurTech

Co-investorsArkin CapitalFuel VenturesHeartfelt CapitalHEARTFELT_InsurTechEight Roads Ventures+5 more

Eleos Healtheleos.healthinNov 2023 · $40M

Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.

AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US

Alon Joffe(Founder)inDror Zaide(Founder)inAlon Rabinovich(Founder)inDenny Morrison(Chief Clinical Officer)inRaz Karmi(Chief Information Security Officer)inNoam Cohen(VP of R&D)in

Co-investorsArkin CapitalArkin Digital HealthF-Prime CapitalGaingelsGreenfield PartnersLool Ventures+5 more

GK8gk8.io𝕏Sep 2019acquired by Celsius Network

GK8 developed self-managed digital asset custody technology for institutions, including a patented air-gapped cold vault and MPC-based wallet infrastructure.

Crypto & Web3CybersecurityFintech

Lior Lamesh(Founder)in

Co-investorsCV VCIN VentureiAngelsIsrael Innovation Authority

GraphiteRxgraphiterx.comin

GraphiteRx operates a marketplace platform that connects pharmacies, hospitals, clinics, and suppliers to streamline healthcare distribution.

AI & Machine LearningB2B MarketplacesEnterprise SoftwareHealthtech

Co-investorsBowery CapitalHumans Of The InternetLool VenturesNew Era Capital Partners

Igentifyigentify.cominSep 2019

iGentify provides a platform combining patient engagement and clinical data management for healthcare providers.

AI & Machine LearningDigital HealthHealthtech

Co-investorsEsplanade VenturesLIP Ventures BoutiqueSilvertech VenturesWorld Trade Ventures (WTV)OurCrowd

Kahrkahrbio.comJun 2021 · $47M

Uses proprietary technology to unmask cancer and recruit a targeted immune response.

Co-investorsCancer FocusPeregrine Ventures

Linlin.healthinDec 2025 · $11M

Lin Health provides virtual, evidence-based behavioral healthcare for people with chronic pain, using the Collaborative Care model and a technology platform to address the underlying causes of pain rather than only symptoms.

Digital HealthHealthtechMental HealthWellness & Fitness

Yehuda Kogan(Founder)in

Co-investorsLIP Ventures BoutiqueSaban VenturesShoni Health VenturesViola VenturesMayo Clinic VenturesOsage Venture Partners+1 more

Lutris Pharmalutris-pharma.comin

Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise.

BiotechDigital HealthHealthtechMedical Devices

Antoni Ribas, M.D., Ph.D.(Founder and Chairman of the Board)Sumant Ramachandra(Chief Executive Officer and Board Director)inJonathan Benjamin(Clinical Development Lead)

Co-investorsPeregrine VenturesPontifax Venture CapitalArkin CapitalColumbus Venture Partners

Lyfegenlyfegen.comin𝕏Sep 2022 · $8M

Lyfegen provides a software platform for managing value-based and outcome-based healthcare contracts and drug pricing agreements between pharmaceutical companies, health insurers (payers), and providers.

Digital HealthHealthtechSaaSBasel, CH

Girisha Fernando(CEO & Founder)inMichel Mohler(CFO & Founder)Nico Julian Mros(CXO & Founder)in

Co-investorsAPEX VenturesTX Ventures

MOBILion Systems, Inc.mobilionsystems.comin𝕏Series B · Aug 2020 · $35M

MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science.

BiotechDeep TechHardwareExton, US

MELISSA SHERMAN(Executive Officer, Director)in

BoardJASON SMITH(Director)inMICHAEL ALBIN(Director)JUDIT LOSONCZI(Director)HEINER DREISMANN(Director)

Co-investorsAnzu PartnersArgonautic VenturesiSelect FundCultivation Capital

NanoGhostnano-ghost.com

NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads.

BiotechDeep TechHealthtech

Marcelle Machluf(Professor (technology inventor))

Omada AIomada.ai

Omada is an AI-powered marketing platform that automates organic growth for local businesses through social media management, Google Business Profile optimization, content creation, and lead capture without requiring paid advertising.

AI & Machine LearningMarketing TechSaaS

Andrew Miller (Mounier)(Founder)in

Co-investorsCrosslink CapitalHubSpot VenturesMotier VenturesBlumberg CapitalFoundersX VenturesGradient Ventures+1 more

Plexiumplexium.cominJul 2025

Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.

AI & Machine LearningBiotechDeep TechSan Diego, US

Michael Martin, Ph.D.(Chief Executive Officer, President)Jorge F. DiMartinoinMichael Martin(President, Chief Executive Officer)inStephen Mullennix(Executive Officer)inSerge Messerlian, M.Sc., M.B.A.(Chief Executive Officer)

BoardSerge Messerlian(Director)in

Co-investorsCRV (Charles River Ventures)DCVC (Data Collective)M VenturesNeotribe VenturesPivotal Life SciencesSoftBank Vision Fund+3 more

Positive Developmentpositivedevelopment.comin𝕏Series C · Aug 2025 · $52M

Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.

Digital HealthHealthtechMedical DevicesMental HealthMclean, US

Mike Suiters(Executive Officer, Director)inNick Whitehead(Director)in

BoardAdam Seabrook(Director)inDaniel Gebremedhin(Director)John Banta(Director)inBrenton Fargnoli(Director)in

Co-investorsAlleyCorpB Capital GroupB4 CapitalFlare Capital PartnersLifeforce CapitalObvious Ventures+3 more

PrognomIQprognomiq.comin𝕏Sep 2020 · $55M

PrognomiQ is a clinical-stage company developing blood-based tests for early detection and treatment of cancer and other complex diseases using multi-omics data.

AI & Machine LearningBiotechHealthtechSan Mateo, US

Philip Ma, Ph.D.(Executive Officer, Director)Philip Ma(Chief Executive Officer & Founder)inOmid Farokhzad(Chair of the Board of Directors)inDavid Siewers(Chief Financial Officer)inBrian Koh(Chief Medical Officer)inBruce Wilcox(Chief Technology Officer)in

Co-investorsCatalio Capital Management, LPWingMaverick Ventures

Seerhelloseer.comin𝕏Dec 2019

Seer provides a platform for sales associates in luxury retail to create and share customized lookbooks and style recommendations with clients.

Enterprise SoftwareRetail TechSaaSSan Francisco, US

Christina Czap(Co-Founder, CEO)inFelipe Saint-Jean(Co-Founder, CTO)inPaul Draper(CTO)Olivia Renaud(Head of Product)Clare Bruzek(Head of Operations)Kathleen Walsh(Marketing \u0026 Sales)

Co-investorsOpen Opportunity FundPioneerY CombinatorEsas VenturesFoundation CapitalGlobal Founders Capital+4 more

Sophia Geneticssophiagenetics.comin𝕏Oct 2020 · $110M

SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics.

AI & Machine LearningBiotechDigital HealthMedical Devices

Jurgi Camblong(Founder)Lars Steinmetz(Founder)Pierre Hutter(Founder)

Co-investors360 CapitalBalderton CapitalCompoundHitachi VenturesACE & CompanyAlychlo+2 more

Theranica Bio-Electronicstheranica.comin𝕏

Theranica develops non-invasive, drug-free wearable therapeutic devices for pain treatment, combining neuroscience research with mobile digital technology.

Digital HealthHealthtechMedical Devices

Alon Ironi(Founder)in

Co-investorsLionBirdVivo CapitalLightspeed Venture Partners

Ultima Genomicsultimagenomics.comin𝕏

Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.

BiotechDeep TechHealthtechMedical Devices

Gilad Almogy(Founder)in

Co-investorsAndreessen HorowitzGeneral AtlanticKhosla VenturesLightspeed Venture PartnersPlayground GlobalPotentum Partners+1 more

Yissumyissum.co.ilin𝕏

YISSUM is a technology transfer organization founded in 1964 that commercializes research from the Hebrew University, connecting groundbreaking academic innovations with industry partners and global markets.

AgTechAI & Machine LearningBiotechDeep TechEnterprise SoftwareJerusalem, IL

Co-investorsPix Vine Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

DZZOM DelawareHometown Medical HoldingsAdicetAir DoctorAyala PharmaceuticalsBiosplice TherapeuticsBreeoot ClinicCartiHealCAVOSColtac TherapeuticsDayTwoHopscotch Primary CareIBEXLin HealthMetaSightMetaSight DiagnosticsMiNA TherapeuticsNectin TherapeuticsPacegenixSmart Medical SystemsTheranicaZebra Medical Vision

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.